This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Learn about ways to make quick money legally. These safe options will help you boost your income without any risks.
16,915 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Figma stock has fallen in 2026 as AI-powered competitors gain ground. This guide breaks down whether the decline crea...
Goldman Sachs lifts its inflation forecast and trims growth as oil prices surge on Hormuz disruptions, pushing recess...
Two popular total stock market ETFs—SCHB and VTI—offer broad U.S. exposure with ultra-low costs. This guide breaks do...
Lucid has built a reputation for rapid delivery gains, echoing early EV winners. This deep dive explains why the stoc...
Unpack GEO Group's Q1 2026 earnings through the transcript lens. Learn what drove revenue, how margins held up, and w...
Retail investors chasing nat gas bets via front-month futures confront a hidden drag. The roll yield trap that gnaws ...
MP Materials jumped about 30% in a month, signaling growing investor interest in U.S. rare-earth supply. This article...
SpaceX IPO plans could redefine the space economy, but Blue Origin is positioned to challenge. Learn how to evaluate ...
The VanEck PFXF ETF focuses on non-financial preferred securities, offering a ~6.7% yield. But investors must watch c...
Two heavyweight names in cloud security are navigating a shifting enterprise landscape. This analysis dives into the ...
A JPMorgan client note argues that Strategy may purchase as much as $30 billion of Bitcoin in 2026, placing Bitcoin i...